thymine has been researched along with Idiopathic Parkinson Disease in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Certain mutations (TT homozygous; CT heterozygous; CC wild-type) of the methylenetetrahydrofolate (MTHFR) gene and long-term levodopa application in patients with Parkinson's disease (PD) support onset of hyperhomocysteinemia." | 7.72 | MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. ( Kuhn, W; Müller, T; Woitalla, D, 2004) |
| "Certain mutations (TT homozygous; CT heterozygous; CC wild-type) of the methylenetetrahydrofolate (MTHFR) gene and long-term levodopa application in patients with Parkinson's disease (PD) support onset of hyperhomocysteinemia." | 3.72 | MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. ( Kuhn, W; Müller, T; Woitalla, D, 2004) |
| "Congenital hydrocephalus (CH) is caused by genetic mutations, but whether factors impacting human genetic mutations are disease-specific remains elusive." | 2.72 | Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions. ( Hart, C; McKnight, I; Park, IH; Shim, JW, 2021) |
| " We found that early accumulation of KARs occurs in the DA neurons of the parkinQ311X mouse, and that chronic administration of the KAR antagonist UBP310 prevents DA neuron loss." | 1.56 | Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. ( Albanese, F; Bagnati, R; Cattaneo, S; Ciammola, A; Consalez, GG; Croci, L; Davoli, E; Di Fonzo, A; Mercatelli, D; Morari, M; Novello, S; Passafaro, M; Passoni, A; Regoni, M; Sassone, J; Serratto, GM; Taverna, S; Valtorta, F; Zanetti, L, 2020) |
| "Monogenic forms of Parkinson's disease (PD) provide an opportunity to examine mechanisms underlying phenotypic variation." | 1.34 | Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease. ( Athanassiadou, A; Bonifati, V; Di Iorio, G; Golbe, LI; Johnson, WG; Markopoulou, K; Papapetropoulos, S; Spychala, JR; Stenroos, ES; Vance, JM; Watts, RL; Williams, TA, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, M | 1 |
| Conrad, J | 1 |
| Barrett, E | 1 |
| Legg, K | 1 |
| Ivey, G | 1 |
| Lee, PHU | 1 |
| Yung, YC | 1 |
| Shim, JW | 2 |
| McKnight, I | 1 |
| Hart, C | 1 |
| Park, IH | 1 |
| Regoni, M | 1 |
| Cattaneo, S | 1 |
| Mercatelli, D | 1 |
| Novello, S | 1 |
| Passoni, A | 1 |
| Bagnati, R | 1 |
| Davoli, E | 1 |
| Croci, L | 1 |
| Consalez, GG | 1 |
| Albanese, F | 1 |
| Zanetti, L | 1 |
| Passafaro, M | 1 |
| Serratto, GM | 1 |
| Di Fonzo, A | 1 |
| Valtorta, F | 1 |
| Ciammola, A | 1 |
| Taverna, S | 1 |
| Morari, M | 1 |
| Sassone, J | 1 |
| Gopalai, AA | 1 |
| Lim, SY | 1 |
| Aziz, ZA | 1 |
| Lim, SK | 1 |
| Tan, LP | 1 |
| Chong, YB | 1 |
| Tan, CT | 1 |
| Puvanarajah, S | 1 |
| Viswanathan, S | 1 |
| Kuppusamy, R | 1 |
| Tan, AH | 1 |
| Lim, TT | 1 |
| Eow, GB | 1 |
| Norlinah, MI | 1 |
| Li, HH | 1 |
| Zhao, Y | 1 |
| Ahmad-Annuar, A | 1 |
| Woitalla, D | 1 |
| Kuhn, W | 1 |
| Müller, T | 1 |
| Hong, CJ | 1 |
| Liu, HC | 1 |
| Liu, TY | 1 |
| Liao, DL | 1 |
| Tsai, SJ | 1 |
| Golbe, LI | 1 |
| Di Iorio, G | 1 |
| Markopoulou, K | 1 |
| Athanassiadou, A | 1 |
| Papapetropoulos, S | 1 |
| Watts, RL | 1 |
| Vance, JM | 1 |
| Bonifati, V | 2 |
| Williams, TA | 1 |
| Spychala, JR | 1 |
| Stenroos, ES | 1 |
| Johnson, WG | 1 |
| Grünewald, A | 1 |
| Breedveld, GJ | 1 |
| Lohmann-Hedrich, K | 1 |
| Rohé, CF | 1 |
| König, IR | 1 |
| Hagenah, J | 1 |
| Vanacore, N | 1 |
| Meco, G | 1 |
| Antonini, A | 1 |
| Goldwurm, S | 1 |
| Lesage, S | 1 |
| Dürr, A | 1 |
| Binkofski, F | 1 |
| Siebner, H | 1 |
| Münchau, A | 1 |
| Brice, A | 1 |
| Oostra, BA | 1 |
| Klein, C | 1 |
| Lücking, CB | 1 |
| Kösel, S | 1 |
| Mehraein, P | 1 |
| Graeber, MB | 1 |
| Barbieri, S | 1 |
| Hofele, K | 1 |
| Wiederhold, KH | 1 |
| Probst, A | 1 |
| Mistl, C | 1 |
| Danner, S | 1 |
| Kauffmann, S | 1 |
| Sommer, B | 1 |
| Spooren, W | 1 |
| Tolnay, M | 1 |
| Bilbe, G | 1 |
| van der Putten, H | 1 |
3 reviews available for thymine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
X-linked hydrocephalus genes: Their proximity to telomeres and high A + T content compared to Parkinson's disease.
Topics: Animals; Genes, X-Linked; Humans; Hydrocephalus; Mice; Mutation; Parkinson Disease; Rats; Telomere; | 2023 |
Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
Topics: Adenine; Alzheimer Disease; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes; Databases, G | 2021 |
Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice.
Topics: Adenine; alpha-Synuclein; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Humans; Lewy Bo | 2001 |
7 other studies available for thymine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity.
Topics: Alanine; Animals; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Female; GluK2 Kaina | 2020 |
Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Case-Control Studies; China; Cohort Studies; Cy | 2013 |
MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cytosine; Female; Folic Acid; Humans; Hyperhom | 2004 |
Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.
Topics: Age Distribution; Age of Onset; Aged; Asian People; Base Sequence; Brain; Brain Chemistry; Cytosine; | 2005 |
Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.
Topics: Adenine; Adult; Age of Onset; Aged; Aged, 80 and over; Alleles; alpha-Synuclein; Glutathione Transfe | 2007 |
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.
Topics: Base Sequence; Cytosine; DNA, Complementary; Family; Female; Genetic Carrier Screening; Homozygote; | 2007 |
Absence of the mitochondrial A7237T mutation in Parkinson's disease.
Topics: Adenine; Base Sequence; DNA Primers; DNA, Mitochondrial; Electron Transport Complex IV; Frontal Lobe | 1995 |